Session » Epidemiology and Public Health (ACR): Rheumatoid Arthritis Pathogenesis and Treatment
-
Abstract Number: 2014
Performance of Self-Reported Measures for Periodontitis in Rheumatoid Arthritis and Osteoarthritis
-
Abstract Number: 2015
Fine Particulate Air Pollution and Systemic Autoimmune Rheumatic Disease in Two Canadian Provinces
-
Abstract Number: 2016
Occupation and Risk of Developing Rheumatoid Arthritis
-
Abstract Number: 2017
Fish Consumption and Risk of Rheumatoid Arthritis Among Women in Large Prospective Cohorts
-
Abstract Number: 2018
Do Mediterranean or Vegetarian Diets Influence Risk of Rheumatoid Arthritis?
-
Abstract Number: 2020
Circulating Carotenoids and Subsequent Risk of Rheumatoid Arthritis
-
Abstract Number: 2021
The Association Between Rheumatoid Factor and Cardiovascular Disease in Healthy Adults
-
Abstract Number: 2022
First Nations Persons Have an Increased Risk of Developing Rheumatoid Arthritis with an Early Onset Age but Are Seen Less Frequently By Rheumatologists: A Population Based Study
-
Abstract Number: 2023
Prevalence of Inflammatory Arthritis Conditions in the First Nations Population of Alberta
-
Abstract Number: 2024
Prevalence of Rheumatoid Arthritis in French West Indies, an African Ancestry Population. the Eppra Study
-
Abstract Number: 2025
Factors Associated with Time to Diagnosis from Symptom Onset in Early Rheumatoid Arthritis Patients
-
Abstract Number: 2026
Treatment Delays and Worse Outcomes Associated with Lower Socioeconomic Status in Rheumatoid Arthritis
-
Abstract Number: 2027
Higher Educational Level Correlates with Retarded Onset and Less Severe Disease in Rheumatoid Arthritis Patients
-
Abstract Number: 2028
Effect of Age at Rheumatoid Arthritis Onset on Clinical, Radiographic, and Functional Outcomes: The Espoir Cohort
-
Abstract Number: 2029
Treatment Patterns of Multimorbid Rheumatoid Arthritis Patients: Results from an International Cross-Sectional Study
-
Abstract Number: 2030
Predicting Failure of Conventional Disease Modifying Antirheumatic Drugs in Treatment Naive Early Rheumatoid Arthritis Patients: A Single Centre Inception Prognostic Factor Cohort Study
-
Abstract Number: 2031
Early Adherence to Methotrexate in Rheumatoid Arthritis (RA) Is High: a Prospective Longitudinal Study of New Users
-
Abstract Number: 2032
Psychological Factors Predict Adherence to Methotrexate (MTX) in Rheumatoid Arthritis (RA); Findings from a Systematic Review of Rates, Predictors and Associations with Patient Outcomes
-
Abstract Number: 2033
Patient Factors Associated with Oral Glucocorticoid Prescribing Patterns in UK Primary Care for Patients with Rheumatoid Arthritis
-
Abstract Number: 2034
A Treat-to-Target Strategy Preserves Work Capacity in Early Rheumatoid Arthritis (RA)
-
Abstract Number: 2035
Joint Distribution and Outcome in 350 Patients with Monoarthritis of Less Than 16 Weeks Duration: Data from a Multicenter Longitudinal Observational Study in Eastern Norway
-
Abstract Number: 2036
Biologic Disease-Modifying Antirheumatic Drugs and Risk of High-Grade Cervical Dysplasia and Cervical Cancer in Women with RA
-
Abstract Number: 2037
Incidence and Prevalence of Myasthenia Gravis in Rheumatoid Arthritis Patients with and without Treatment Compared with the General Population
-
Abstract Number: 2040
Opportunistic Infections in Patients Treated with Biologic Drug Therapy
-
Abstract Number: 2042
Tuberculin Conversion in Patients with Autoimmune Arthropathies Receiving Biologic Therapy
-
Abstract Number: 2043
How Correct Are the Assumptions Made for Tuberculosis Screening Algorythms before TNF-Alpha Antagonists?
-
Abstract Number: 2044
Systematic Review of the Effect of Anti-Rheumatic Therapies upon Vaccine Immunogenicity